Lu R, Wang T, Lee S, Chen S, Chang Y, Chen P
Drug Alcohol Depend. 2019; 204:107516.
PMID: 31513981
PMC: 7077753.
DOI: 10.1016/j.drugalcdep.2019.06.018.
Sordo L, Barrio G, Bravo M, Indave B, Degenhardt L, Wiessing L
BMJ. 2017; 357:j1550.
PMID: 28446428
PMC: 5421454.
DOI: 10.1136/bmj.j1550.
Manhapra A, Quinones L, Rosenheck R
Drug Alcohol Depend. 2016; 160:82-9.
PMID: 26804898
PMC: 4767635.
DOI: 10.1016/j.drugalcdep.2015.12.035.
Zhang L, Zou X, Zhang D, Li X, Zhao P, Ling L
PLoS One. 2015; 10(10):e0139942.
PMID: 26484772
PMC: 4618733.
DOI: 10.1371/journal.pone.0139942.
Sun H, Li X, Chow E, Li T, Xian Y, Lu Y
BMJ Open. 2015; 5(1):e005997.
PMID: 25573521
PMC: 4289728.
DOI: 10.1136/bmjopen-2014-005997.
Illicit opioid intoxication: diagnosis and treatment.
Fareed A, Stout S, Casarella J, Vayalapalli S, Cox J, Drexler K
Subst Abuse. 2012; 5:17-25.
PMID: 22879747
PMC: 3411502.
DOI: 10.4137/SART.S7090.
Drug and alcohol dependence : the past decade and future, view from a development country.
Mohan D, Adityanjee , Saxena S, Sethi H
Indian J Psychiatry. 2011; 25(4):269-74.
PMID: 21847303
PMC: 3012299.
Pharmacotherapy in the treatment of addiction: methadone.
Kreek M, Borg L, Ducat E, Ray B
J Addict Dis. 2010; 29(2):200-16.
PMID: 20407977
PMC: 2885886.
DOI: 10.1080/10550881003684798.
Effects of receiving additional off-site services on abstinence from illicit drug use among men on methadone: a longitudinal study.
Wu E, El-Bassel N, Gilbert L, Chang M, Sanders G
Eval Program Plann. 2009; 33(4):403-9.
PMID: 20034671
PMC: 2891366.
DOI: 10.1016/j.evalprogplan.2009.11.001.
Pharmacotherapy of dual substance abuse and dependence.
Kenna G, Nielsen D, Mello P, Schiesl A, Swift R
CNS Drugs. 2007; 21(3):213-37.
PMID: 17338593
DOI: 10.2165/00023210-200721030-00003.
Strategies for preventing heroin overdose.
Sporer K
BMJ. 2003; 326(7386):442-4.
PMID: 12595388
PMC: 1125320.
DOI: 10.1136/bmj.326.7386.442.
Treatment of heroin (diamorphine) addiction: current approaches and future prospects.
Gonzalez G, Oliveto A, Kosten T
Drugs. 2002; 62(9):1331-43.
PMID: 12076182
DOI: 10.2165/00003495-200262090-00004.
The impact of harm-reduction-based methadone treatment on mortality among heroin users.
Langendam M, van Brussel G, Coutinho R, van Ameijden E
Am J Public Health. 2001; 91(5):774-80.
PMID: 11344886
PMC: 1446673.
DOI: 10.2105/ajph.91.5.774.
A risk-benefit analysis of methadone maintenance treatment.
Bell J, Zador D
Drug Saf. 2000; 22(3):179-90.
PMID: 10738842
DOI: 10.2165/00002018-200022030-00002.
Methadone maintenance treatment in opiate dependence: a review.
Farrell M, Ward J, Mattick R, Hall W, Stimson G, Des Jarlais D
BMJ. 1994; 309(6960):997-1001.
PMID: 7950725
PMC: 2541312.
DOI: 10.1136/bmj.309.6960.997.
Evaluation of drug abuse rehabilitation efforts: a review.
Quinones M, Doyle K, Sheffet A, Louria D
Am J Public Health. 1979; 69(11):1164-9.
PMID: 507249
PMC: 1619285.
DOI: 10.2105/ajph.69.11.1164.
